Physician

Richard D Ramos, MD

According to 2025 Medicare claims, Richard Ramos, MD (NPI: 1366444358) practices interventional pain management (ipm) in the Greensboro-High Point, NC market, with the plurality of this provider's patient population coming from Guilford, NC. This provider's primary affiliated billing organization is EMERGEORTHO PA (NPI: 1376592964; TIN: 561079264) and primary practice location at 27408-7602. Ramos is affiliated with the Triad HealthCare Network, LLC. (ACO ID: D0209), participating under the REACH model.

Ramos' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 596 traditional Medicare patients, billed 9,182 HCPCS/CPT codes, and received $217,722 in Medicare payments. The top billing code was 64483 (Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level). Part D data shows 5,408 prescription claims across 1,036 beneficiaries totaling $183,293 in drug costs, led by Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen). 2021 DME data shows 12 claims. Open Payments data shows 10 records totaling $367. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $243,337 and ending at $183,293. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	951	6,346	$276,298
2016	951	5,688	$263,769
2017	967	5,996	$281,873
2018	871	8,135	$246,861
2019	863	10,428	$242,002
2020	734	9,043	$206,818
2021	753	10,646	$260,653
2022	782	11,314	$264,972
2023	718	8,977	$246,314
2024	596	9,182	$217,722

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	676	3,559	$243,337
2016	707	3,502	$219,061
2017	826	4,936	$255,642
2018	815	5,309	$258,916
2019	811	4,603	$223,733
2020	760	3,813	$160,899
2021	756	3,315	$143,805
2022	844	3,820	$171,912
2023	1,025	6,181	$237,788
2024	1,036	5,408	$183,293

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	12	$550
2016	N/R	12	$1,196
2017	N/R	14	$573
2018	N/R	12	$488
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	12	$427
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
64483	Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level	129	199	$196
62323	Injection of substance into lower spine canal using imaging guidance	127	155	$176
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	294	458	$90
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	128	175	$12
J1100	Injection, dexamethasone sodium phosphate, 1 mg	278	5,871	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	838	20,956	$24,472
Oxycontin	Oxycodone Hcl	31	930	$23,178
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	996	22,754	$21,915
Oxycodone Hcl	Oxycodone Hcl	693	18,451	$13,054
Xtampza Er	Oxycodone Myristate	12	350	$12,943

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	10	$367	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Richard D. Ramos, MD?

Tedicare shows public-source Medicare data for Richard D. Ramos, MD (NPI 1366444358), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Richard D. Ramos, MD have ACO affiliation data?

Richard D. Ramos, MD is shown with ACO affiliation data for Triad HealthCare Network, LLC. (REACH, ACO ID D0209).

What billing organization is linked to Richard D. Ramos, MD?

Richard D. Ramos, MD is linked to EMERGEORTHO PA (billing NPI 1376592964) in the available physician profile data.

Does Richard D. Ramos, MD have Open Payments data?

Richard D. Ramos, MD has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.